Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,386 | -134,232 | -87,317 | -38,882 | -112,232 |
| Depreciation Amortization | 4,321 | 3,109 | 1,760 | 1,059 | 1,433 |
| Accounts payable and accrued liabilities | 2,201 | 2,085 | 9,874 | 592 | 4,588 |
| Other Working Capital | 11,420 | 1,285 | 9,547 | -3,488 | 14,440 |
| Other Operating Activity | 40,565 | 31,649 | 11,088 | 10,001 | 11,251 |
| Operating Cash Flow | $-126,879 | $-96,104 | $-55,048 | $-30,718 | $-80,520 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,172 | -23,886 | -23,843 | -19,096 | -170,460 |
| PPE Investments | -17,642 | -10,823 | -4,811 | -801 | -1,146 |
| Purchase Sale Intangibles | -8,000 | -7,500 | -2,000 | -500 | -500 |
| Other Investing Activity | -8,000 | -7,500 | -2,000 | -500 | -500 |
| Investing Cash Flow | $-45,814 | $-42,209 | $-30,654 | $-20,397 | $-172,106 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 166,994 | 166,539 | 166,495 | 165,886 | 228,754 |
| Other Financing Activity | -338 | -338 | -338 | -252 | 0 |
| Financing Cash Flow | $166,656 | $166,201 | $166,157 | $165,634 | $228,754 |
| Beginning Cash Position | 135,002 | 135,002 | 135,002 | 135,002 | 158,874 |
| End Cash Position | 128,965 | 162,890 | 215,457 | 249,521 | 135,002 |
| Net Cash Flow | $-6,037 | $27,888 | $80,455 | $114,519 | $-23,872 |
| Free Cash Flow | |||||
| Operating Cash Flow | -126,879 | -96,104 | -55,048 | -30,718 | -80,520 |
| Capital Expenditure | -17,642 | -10,823 | -4,811 | -801 | -1,146 |
| Free Cash Flow | -144,521 | -106,927 | -59,859 | -31,519 | -81,666 |